Working… Menu

Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer (PREDIXIIHER2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03894007
Recruitment Status : Terminated (Security and effect data from another ongoing study.)
First Posted : March 28, 2019
Last Update Posted : September 23, 2021
Information provided by (Responsible Party):
Renske Altena, Karolinska University Hospital

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 30, 2021
Actual Study Completion Date : June 30, 2021